CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)	Series B Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance preferred stock, shares at Dec. 31, 2018	60,000
Balance common stock, shares at Dec. 31, 2018		934,568,736
Balance, value at Dec. 31, 2018	$ 60	$ 934,569	$ 18,028,413	$ (25,021,933)	$ (6,058,891)
Allocated value of warrants and beneficial conversion feature related to issuance of convertible debt			43,220		43,220
Issuance of common stock for convertible promissory notes and accrued interest, shares		10,971,221
Issuance of common stock for convertible promissory notes and accrued interest, value		$ 10,971	(4,827)		6,144
Net loss				(450,552)	(450,552)
Balance preferred stock , shares at Mar. 31, 2019	60,000
Balance common stock, shares at Mar. 31, 2019		945,539,957
Balance, value at Mar. 31, 2019	$ 60	$ 945,540	18,066,806	(25,472,485)	$ (6,460,079)
Balance preferred stock, shares at Dec. 31, 2019	60,000
Balance common stock, shares at Dec. 31, 2019		985,359,957			985,539,957
Balance, value at Dec. 31, 2019	$ 60	$ 985,540	18,524,842	(26,961,606)	$ (7,451,164)
Issuance of common stock for convertible debt and accrued interest, shares		103,447,553
Issuance of common stock for convertible debt and accrued interest, value		$ 103,448	18,752		122,200
Allocated value of warrants and beneficial conversion feature related to issuance of convertible debt			145,481		145,481
Issuance of common stock for Series B Preferred Stock , shares	(10,978)	36,519,609
Issuance of common stock for Series B Preferred Stock, value	$ (11)	$ 36,519	(36,508)
Net loss				(452,307)	$ (452,307)
Balance preferred stock , shares at Mar. 31, 2020	49,202
Balance common stock, shares at Mar. 31, 2020		1,125,327,119			1,125,507,119
Balance, value at Mar. 31, 2020	$ 49	$ 1,125,507	$ 18,652,567	$ (27,413,913)	$ (7,635,790)